11,460 bottles pulled nationwide; NC patients may be affected
FDA RECALL: Rising Pharma Holdings, Inc. has issued a nationwide Class II recall of 11,460 bottles of chlorthalidone tablets, USP, 25 mg, after the medication failed dissolution testing, meaning tablets may not break down properly in the body. The recall includes 100‑count lot RISA24001 and 1,000‑count lot RISB24002, both carrying an expiration date of April 2027.
Chlorthalidone is a commonly prescribed blood pressure medication.
The recalled lots were distributed across the United States, including North Carolina, where pharmacies, clinics, and hospitals may have dispensed affected bottles. Reduced dissolution could result in sub‑therapeutic dosing, particularly concerning for older adults and cardiac‑risk patients.
The FDA classifies this as a Class II recall, indicating the product may cause temporary or medically reversible health effects.
Patients in NC who recently filled chlorthalidone prescriptions should check their bottles and contact their pharmacy for verification.
© 2026 BCDollarSaver.com. All rights reserved.
Be the first to comment